Clinical trials recruiting for Eczema
196
Recruiting trials
41
US states with sites
53
Countries
28%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Dupilumab | 13 |
| Abrocitinib | 8 |
| Lebrikizumab | 3 |
| Tralokinumab | 3 |
| Upadacitinib | 3 |
| BBT001 | 2 |
| Baricitinib | 2 |
| Blood sampling | 2 |
| CM512 | 2 |
| ENV-294 | 2 |
| IBI3002 | 2 |
| Methotrexate | 2 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 36 |
| Florida | 22 |
| Texas | 22 |
| New York | 20 |
| Michigan | 17 |
| Pennsylvania | 17 |
| Maryland | 16 |
| Illinois | 13 |
| Indiana | 13 |
| Alabama | 12 |
| Arkansas | 12 |
| Georgia | 12 |
Top cities
New York, New York 16Los Angeles, California 13Birmingham, Alabama 12Miami, Florida 11San Antonio, Texas 11San Diego, California 11Dallas, Texas 10Philadelphia, Pennsylvania 10Indianapolis, Indiana 9Sacramento, California 9
Self-screener
Recruiting trials
- A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
- A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
- A Clinical Study Evaluating the Application of La Roche-Posay's New B5 Multi-Effect Soothing and Repairing Cream on Individuals With Facial Atopic Dermatitis
- A Clinical Study to Evaluate SM17 for Atopic Dermatitis
- A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
- A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
- A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis
- A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
- A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
- A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis
- A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection
- A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
- A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
- A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
- A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients
- A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis
- A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis
- A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis
- A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers
- A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
- A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
- A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
- A Study of Lebrikizumab in Adults With Nummular Eczema
- A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis
- A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants
- A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)
- A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
- A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic Dermatitis
- A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis
- A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.
- A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis
- A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients
- A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
- A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema
- A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis
- A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis
- A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis
- A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
- A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
- A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions Respond to Dupilumab Treatment
- A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- AI App for Management of Atopic Dermatitis
- Allergy and Immunology Natural History Study
- An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
- An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- An Observational Study of Patients With Dermatologic Disease
- Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.
- Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis
- BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis
- Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis
- Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- Cardamom and Topical Roseomonas in Atopic Dermatitis
- CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis
- Changes in Skin Myco- and Microbiome After Lebrikizumab Treatment
- Characterisation of Skin Microstructure Under Normal and Atrophied States
- Characterization of Chronic Hand Eczema
- China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
- Clinical-Instrumental Study To Evaluate And Compare The Efficacy And Tolerability Of Two Emollients Products In Atopic Dermatitis
- Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
- Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
- CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
- CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
- Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies
- DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema
- Deployment o the Multidisciplinary Prospective Cohort Imminent
- Determinants of Chronic Inflammatory Skin Disease Trajectories
- Dietary Intervention on Atopy
- Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
- Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
- Double-blind, Randomized, Non-inferiority Trial in Atopic Dermatitis: Comparison of Lipikar Balm and Relipid+ Balm in the Treatment of Mild to Moderate Atopic Dermatitis in Children and Adults
- Drug Survival of Target Therapies in Atopic Dermatitis
- Dupilumab De-escalation in Pediatric Atopic Dermatitis
- Dupixent and Narrowband UVB for Atopic Dermatitis
- Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function
- Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population
- Effects of Treatments on Atopic Dermatitis
- Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.
- Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
- Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
- Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases
- Ethnic Differences in Mechanisms of Action of Dupilumab
- Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
- Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children
- Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
- Evaluation by Confocal Reflectance Microscopy of the Skin Structure of Patients With Atopic Dermatitis Treated With Tralokinumab Biotherapy.
- Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis
- Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study
- Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
Related conditions
Trials recruiting for Eczema often also study these conditions. Each links to its own recruiting-trial list.
Atopic dermatitis 126Atopic Dermatitis (AD) 20Psoriasis 233Atopic Dermatitis (Eczema) 12Moderate to Severe Atopic Dermatitis 10Asthma 382Dermatitis Atopic 8Lupus 332Hidradenitis Suppurativa 7Eczema, Atopic 5
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Eczema trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.